Preoperative use of Pregabalin versus Placebo: a randomized, double-blind, controlled trial to assess the Quality of anesthetic recovery in patients undergoing Breast cancer surgery

Faculdade de Medicina de Jundiaí0 个研究点开始时间: 2023年3月14日最近更新: 2023年5月29日

试验速览

暂无简介。

•They will integrate 80 patients aged between 20 and 65 years and physical status ASA I or II, who will undergo elective breast cancer surgeries, performed at the University Hospital of the Faculty of Medicine of Jundiaí (Jundiaí-SP).

•Patient refusal; altered level of consciousness or inability to communicate; presence of any contraindication to the use of any agent described in the project; history of seizure disorder; currently using pregabalin or gabapentin; presence of chronic pain or use of opioids; body mass index (BMI) >40 kg/m2; insulin-dependent diabetes mellitus and renal failure (estimated glomerular filtration rate less than 60 ml/min/1.73 m²); violation of the protocol (such as the use of agents not described in the study protocol); refusal to respond to the questionnaire (QoR-15) in the perioperative period.

发起方

Faculdade de Medicina de Jundiaí